{"id":396599,"date":"2020-12-09T11:03:24","date_gmt":"2020-12-09T16:03:24","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=396599"},"modified":"2020-12-09T11:03:24","modified_gmt":"2020-12-09T16:03:24","slug":"fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","title":{"rendered":"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021"},"content":{"rendered":"

<\/p>\n

FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021<\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nBronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech securities between December 11, 2019 and October 9, 2020 both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/fbio<\/a>.\n<\/p>\n

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. <\/span><\/p>\n

\nThe Complaint alleges that throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) IV Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the FDA would not approve the NDA for IV Tramadol; and (3) as a result, the Company\u2019s public statements were materially false and misleading at all relevant times.\n<\/p>\n

\nA class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm\u2019s site: www.bgandg.com\/fbio<\/a> or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Fortress Biotech you have until January 26, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.\n<\/p>\n

\nBronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm\u2019s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201209005017\/en\/<\/a><\/span><\/p>\n

\nBronstein, Gewirtz & Grossman, LLC
\n
Peretz Bronstein or Yael Hurwitz
\n
212-697-6484 | info@bgandg.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America New York<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 NEW YORK–(BUSINESS WIRE)– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech securities between December 11, 2019 and October 9, 2020 both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/fbio. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. … <\/p>\n

Continue reading “FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-396599","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 NEW YORK–(BUSINESS WIRE)– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech securities between December 11, 2019 and October 9, 2020 both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/fbio. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. … Continue reading "FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-09T16:03:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021\",\"datePublished\":\"2020-12-09T16:03:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\"},\"wordCount\":402,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\",\"name\":\"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-12-09T16:03:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","og_locale":"en_US","og_type":"article","og_title":"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk","og_description":"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 NEW YORK–(BUSINESS WIRE)– Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fortress Biotech, Inc.(“Fortress Biotech” or “the Company”) (NASDAQ: FBIO) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Fortress Biotech securities between December 11, 2019 and October 9, 2020 both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm\u2019s site: www.bgandg.com\/fbio. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. … Continue reading \"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-09T16:03:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021","datePublished":"2020-12-09T16:03:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/"},"wordCount":402,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/","name":"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-12-09T16:03:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201209005017r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fbio-investor-alert-bronstein-gewirtz-grossman-llc-reminds-fortress-biotech-inc-investors-of-class-action-and-lead-plaintiff-deadline-january-26-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=396599"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396599\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=396599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=396599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=396599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}